Top 50 Soleus Capital Management, L.P. Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | 12.06% | 1.15M | $297.9M | +22.53%(+212.03K) | $177.97(+110.75%) | 2026-03-31 | |
| CELC | CELCUITY INC | 5.94% | 1.28M | $146.6M | -28.97%(-523.88K) | $34.17(+215.89%) | 2026-03-31 | |
| TGTX | TG THERAPEUTICS INC | 5.42% | 4.03M | $133.9M | +28.35%(+890.01K) | $26.74(+99.35%) | 2026-03-31 | |
| PODD | INSULET CORP | 4.78% | 562.5K | $118.0M | +275.00%(+412.50K) | $258.06(-36.26%) | 2026-03-31 | |
| NVCR | NOVOCURE LTD | 4.63% | 10.49M | $114.4M | +23.00%(+1.96M) | $18.82(-8.63%) | 2026-03-31 | |
| UTHR | UNITED THERAPEUTICS CORP DEL | 4.5% | 187.2K | $111.0M | +211.98%(+127.19K) | $451.67(+23.08%) | 2026-03-31 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 4.31% | 330.5K | $106.5M | -8.94%(-32.45K) | $55.54(+473.51%) | 2026-03-31 | |
| VCEL | VERICEL CORP | 3.32% | 2.55M | $82.0M | +233.65%(+1.79M) | $34.86(+34.79%) | 2026-03-31 | |
| ALKS | ALKERMES PLC | 2.82% | 1.97M | $69.7M | +49.04%(+648.50K) | $29.87(+82.71%) | 2026-03-31 | |
| ANIP | ANI PHARMACEUTICALS INC | 2.55% | 820.2K | $63.1M | +68.69%(+334.00K) | $78.40(+9.73%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +16.88% | +59.68% |
| Top 20 Holdings Unweighted | +17.19% | +60.94% |
Sign up free to track Soleus Capital Management, L.P., compare funds side by side, and get alerts the moment positions change.